Search research articles
Contact Us
Filters
Showing results (181-190 of 242) with videos related to
Page
of 25
Sort By:
Medicine
|
August 5, 2018
Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
Pegah Golabi, Haley Bush, Maria Stepanova, et al.
Journal of Neuroimmunology
|
August 25, 2019
Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study
Ali A Weinstein, J Michael Estep, Leyla de Avila, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 23, 2017
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes
Zobair M Younossi, Maria Stepanova, Tarik Asselah, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 13, 2026
Twenty-Year Trends in Liver Transplantation Among Hepatitis D Virus-Infected Patients in the U.S. and Europe
Zobair M Younossi, Giacomo Germani, Maria Buti, et al.
Plos One
|
February 25, 2022
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system
Brian Lam, Maria Stepanova, Chapy Venkatesan, et al.
International Journal of General Medicine
|
October 4, 2023
Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women
Jillian Kallman Price, Leyla de Avila, Maria Stepanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 21, 2017
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir
Zobair M Younossi, Maria Stepanova, Stuart Gordon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 23, 2016
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials
Zobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Journal of Viral Hepatitis
|
April 16, 2024
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
Saleh A Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas, et al.
JAMA Network Open
|
September 16, 2021
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
Zobair M Younossi, Sean Felix, Thomas Jeffers, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 242) with videos related to
Sort By:
Page
of 25
Medicine
|
August 5, 2018
Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
Pegah Golabi, Haley Bush, Maria Stepanova, et al.
Journal of Neuroimmunology
|
August 25, 2019
Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study
Ali A Weinstein, J Michael Estep, Leyla de Avila, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 23, 2017
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes
Zobair M Younossi, Maria Stepanova, Tarik Asselah, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 13, 2026
Twenty-Year Trends in Liver Transplantation Among Hepatitis D Virus-Infected Patients in the U.S. and Europe
Zobair M Younossi, Giacomo Germani, Maria Buti, et al.
Plos One
|
February 25, 2022
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system
Brian Lam, Maria Stepanova, Chapy Venkatesan, et al.
International Journal of General Medicine
|
October 4, 2023
Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women
Jillian Kallman Price, Leyla de Avila, Maria Stepanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 21, 2017
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir
Zobair M Younossi, Maria Stepanova, Stuart Gordon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 23, 2016
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials
Zobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Journal of Viral Hepatitis
|
April 16, 2024
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
Saleh A Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas, et al.
JAMA Network Open
|
September 16, 2021
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
Zobair M Younossi, Sean Felix, Thomas Jeffers, et al.
Page
of 25